During the past decade, Spilhaus CRS conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Spilhaus CRS" #1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 2 trials as a collaborator, "HIV Prevention Trials Network" with 2 trials as a collaborator, "Microbicide Trials Network" with 2 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials as a collaborator and "National Institute of Mental Health (NIMH)" with 2 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Spilhaus CRS" are "HIV Infections" (7 trials) and "HIV Infection" (1 trials). Many other conditions were trialed in "Spilhaus CRS" in a lesser frequency.

Most popular intervention types in "Spilhaus CRS" are "Drug" (5 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "CAB LA" (2 trials), "Emtricitabine/tenofovir disoproxil fumarate" (2 trials), "Emtricitabine/tenofovir disoproxil fumarate placebo" (2 trials), "Tenofovir disoproxil fumarate" (2 trials) and "Tenofovir disoproxil fumarate placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Spilhaus CRS" are 7 trials for "Female" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "Spilhaus CRS". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Spilhaus CRS, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Spilhaus CRS, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".